ArticleIn vivo (Athens, Greece)
Outcomes of Enfortumab Vedotin Treatment in Patients Ineligible for the EV-301 Trial.
Kazutaka Nakamura et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
pooled itcites it
ArticleIn vivo (Athens, Greece)
Kazutaka Nakamura et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.